Health Canada and FDA Joint Public Consultation on International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
The Food and Drug Administration (FDA) is announcing a regional public webinar entitled ‘‘Health Canada and United States Food and Drug Administration Joint Public Consultation on International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)’’ to provide information and receive comments on the current activities of ICH as well as the upcoming meetings in Osaka, Japan, in November 2016. The topics to be discussed are the topics for discussion at the forthcoming ICH Assembly Meeting. The purpose of the public meeting is to solicit public input prior to the next ICH Assembly meeting and the Expert Working Groups meetings in Osaka, Japan, scheduled for November 6 through 10, 2016, at which the discussion of the topics underway will continue.
October 24, 2016
1:00 p.m. to 3:00 p.m. EST
Sir Frederick G. Banting Research Centre
251 Sir Frederick Banting Driveway
Ottawa, ON K1Y 0M1, Canada
A website to access the webcast will be emailed to those who those who register for the meeting as a remote attendee.
If you wish to attend the public meeting either in-person or via webcast, please register at the following website: https://www.eventbrite.ca/e/health-canada-us-fda-consultation-on-ich-live-webcast-tickets-27076583791. Registrations may be limited, so early registration is recommended. Registration is free and will be on a first-come, first-served basis. However, the number of participants from each organization may be limited based on space limitations. Registrants will receive confirmation once they have been accepted.
Amanda Roache, email@example.com
Overview of Ongoing ICH Topics (PDF - 2 MB)